Grant: Discovery Grants Program - Individual
University of Toronto
$34,000.00
Engineering the RNA-guided Cascade complex for genome editing
FY 2018-19
Summary
For humans, it took thousands of generations to develop modern domesticated plants and animals. Since the time of Thomas Morgan, scientists have been seeking methods to directly manipulate genomes of different organisms and fix faulty human genes. Precise modifications of complex genomes have been one of the major goals for scientists working in basic and applied science. Molecular tools that are currently used for genome engineering include zinc finger nucleases (ZFNs) and transcription activator-like effector nucleases (TALENs). A major disadvantage of these protein-guided genome engineering systems is that the correction of each new target sequence requires laborious efforts to design a new nuclease that specifically recognizes this target sequence. Therefore, new technologies that are affordable, easy to use and efficient are still needed for the genetic engineering.* Recently, the microbial CRISPR/Cas system has rapidly emerged as an RNA-guided genome editing tool for robust and multiplexable genome engineering. In the CRISPR mechanism, short CRISPR RNAs (crRNAs) guide the CRISPR-associated protein complexes (Cascade) or nucleases (Cas9) to complementary DNA or RNA sequences promoting specific target binding and cleavage. Successful applications of several Cas9 nucleases for genome editing and regulation have already been demonstrated in bacteria, yeast, plants, and human cells. However, the application of the Cascade complex for genome editing remains to be explored. The long-term objective of this research is to understand the molecular mechanisms of activity of Cascade and to design novel RNA-guided systems for efficient genome editing. Using the purified Cascade proteins and their complexes, we will characterize their interaction with synthetic crRNAs and target DNAs. For sequence-specific DNA cleavage and genome editing, we will introduce a nuclease domain into the engineered Cascade complex. These studies will help to optimize the protein and RNA components of engineered Cascade complexes to facilitate their delivery and assembly in targeted cells. The specificity of target recognition and cleavage by engineered Cascade complexes will be characterized in vivo using Escherichia coli and yeast cells as model systems. Our work will promote the development of novel RNA-guided molecular tools for applications in genome editing, gene therapy and biotechnology. *
Program
Discovery Grants Program - Individual
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
RGPIN-2015-04745
Name nom
Yakunin, Alexander
Department département
Chemical Engineering and Applied Chemistry
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2018
Competition year année de concours
2015
Award amount
34000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
1200
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Advancement of knowledge
Area of application fr
Avancement des connaissances
Research subject code
5404
Research subject group en
Biochemistry
Research subject group fr
Biochimie
Research subject en
Enzymes
Research subject fr
Enzymes
Partie
4
Nb partie
5
Application title
Engineering the RNA-guided Cascade complex for genome editing
Keyword
NSERC
Application summary
For humans, it took thousands of generations to develop modern domesticated plants and animals. Since the time of Thomas Morgan, scientists have been seeking methods to directly manipulate genomes of different organisms and fix faulty human genes. Precise modifications of complex genomes have been one of the major goals for scientists working in basic and applied science. Molecular tools that are currently used for genome engineering include zinc finger nucleases (ZFNs) and transcription activator-like effector nucleases (TALENs). A major disadvantage of these protein-guided genome engineering systems is that the correction of each new target sequence requires laborious efforts to design a new nuclease that specifically recognizes this target sequence. Therefore, new technologies that are affordable, easy to use and efficient are still needed for the genetic engineering.* Recently, the microbial CRISPR/Cas system has rapidly emerged as an RNA-guided genome editing tool for robust and multiplexable genome engineering. In the CRISPR mechanism, short CRISPR RNAs (crRNAs) guide the CRISPR-associated protein complexes (Cascade) or nucleases (Cas9) to complementary DNA or RNA sequences promoting specific target binding and cleavage. Successful applications of several Cas9 nucleases for genome editing and regulation have already been demonstrated in bacteria, yeast, plants, and human cells. However, the application of the Cascade complex for genome editing remains to be explored. The long-term objective of this research is to understand the molecular mechanisms of activity of Cascade and to design novel RNA-guided systems for efficient genome editing. Using the purified Cascade proteins and their complexes, we will characterize their interaction with synthetic crRNAs and target DNAs. For sequence-specific DNA cleavage and genome editing, we will introduce a nuclease domain into the engineered Cascade complex. These studies will help to optimize the protein and RNA components of engineered Cascade complexes to facilitate their delivery and assembly in targeted cells. The specificity of target recognition and cleavage by engineered Cascade complexes will be characterized in vivo using Escherichia coli and yeast cells as model systems. Our work will promote the development of novel RNA-guided molecular tools for applications in genome editing, gene therapy and biotechnology. *